Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Special Counsel Kate Legge joins Pearce IP

by | Feb 17, 2021

Boutique specialist firm Pearce IP is delighted to announce that Special Counsel, Kate Legge commenced with Pearce IP this week.

Kate is an IP and patent lawyer with more than 20 years’ experience providing IP leadership for pharmaceutical product development and commercialisation in global markets.  She has developed and implemented global IP strategies for more than 15 years’ within multi-national pharmaceutical companies.  She is an Australian qualified and registered legal practitioner, and has a Master’s degree in IP Law and a BSc in biochemistry.

Kate obtained foundational training in IP licensing and commercialisation (IT and pharma) at Norton Rose (then Deacons Graham & James), King & Wood Mallesons (then Mallesons Stephen Jaques) and Australia’s Telstra Corporation. Most recently, Kate was in-house IP Counsel at Pfizer, where she was responsible for all IP issues relating to a portfolio of small molecule and complex/value-added generic products.  She held similar roles at Pfizer predecessors Hospira and Mayne Pharma, listed in the US and Australia respectively, which were ultimately acquired by Pfizer.  

Pearce IP’s Principal Lawyer Naomi Pearce says:

“Kate is among a handful of Australian patent litigators who have been at the front-line, managing game-changing global patent issues for pharma/biopharma companies for decades. Her more than 15 years’ experience in-house sets her apart as a strategic and commercial patent lawyer, and her background in biochemistry brings invaluable technical insight to her work product.  We are delighted to welcome Kate to Pearce IP.”

Naomi Pearce

Naomi Pearce

CEO, Executive Lawyer, Patent & Trade Mark Attorney

Naomi is the founder of Pearce IP, and is one of Australia’s leading IP practitioners.   Naomi is a market leading, strategic, commercially astute, patent lawyer, patent attorney and trade mark attorney, with over 25 years’ experience, and a background in molecular biology/biochemistry.  Ranked in virtually every notable legal directory, highly regarded by peers and clients, with a background in molecular biology, Naomi is renown for her successful and elegant IP/legal strategies.

Among other awards, Naomi is ranked in Chambers, IAM Patent 1000, IAM Strategy 300, is a MIP “Patent Star”, and is recognised as a WIPR Leader for patents and trade marks. Naomi is the 2023 Lawyers Weekly “IP Partner of the Year”, the 2022 Lexology client choice award recipient for Life Sciences, the 2022 Asia Pacific Women in Business Law “Patent Lawyer of the Year” and the 2021 Lawyers Weekly Women in Law SME “Partner of the Year”.  Naomi is the founder of Pearce IP, which commenced in 2017 and won 2021 “IP Team of the Year” at the Australian Law Awards.

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.

Our Latest News